This is where compounding pharmacies come in
The potential of GHK as an anti-aging peptide
if pancreatitis is confirmed, do not resume semaglutide
What this means in practice: Compounding pharmacies that halted GHK-Cu production in 2023 can begin preparing to restock (once July guidance is finalized) Clinicians prescribing peptide protocols will have legitimate, pharmaceutical-grade sourcing options again Patients who've been sourcing from unregulated channels will have access to properly tested product Quality and safety will improve compounded products from licensed facilities must meet USP standards for purity and sterility What This Doesn't Mean This is not FDA approval
A comprehensive systematic review and meta-analysis published in the Journal of Translational Medicine analyzed data from seven distinct studies encompassing over 400 patients
Gros R, You X, Baggio LL, Kabir MG, Sadi AM, Mungrue IN, et al